The SJL mouse strain has been widely used as an animal model for experiment
al autoimmune encephalitis (EAE), inflammatory muscle disease and lymphomas
and has also been used as a background strain for the generation of animal
models for a variety of diseases including motor neurone disease, multiple
sclerosis and atherosclerosis. Recently the SJL mouse was shown to have my
opathy due to dysferlin deficiency, so that it can now be considered a natu
ral animal model for limb-girdle muscular dystrophy type 2B (LGMD2B) acid M
iyoshi myopathy (MM). We have cloned the mouse dysferlin cDNA and analysis
of the sequence shows that the mouse dysferlin gene is characterized by six
C2 domain sequences and a C-terminal anchoring domain. with the human and
the mouse dysferlin genes sharing >90% sequence homology overall. Genomic a
nalysis of the SJL mutation confirms that the 171 bp RNA deletion has arise
n by exon skipping resulting from a splice site mutation. The identificatio
n of this mutation has implications for the various groups using this widel
y available mouse stock. NeuroReport 12:625-629 (C) 2001 Lippincott William
s & Wilkins.